Clinical trial
Study of Autologous Bone Marrow Concentrate for the Treatment of Critical Limb…
NCT00498069 · Harvest Technologies, Industry · Completed
Key facts
| NCT number | NCT00498069 |
|---|---|
| Title | Study of Autologous Bone Marrow Concentrate for the Treatment of Critical Limb Ischemia (CLI) |
| Official title | Feasibility Study of the Safety and Activity of Autologous Bone Marrow Aspirate Concentrate (BMAC) for the Treatment of Critical Limb Ischemia Due to Peripheral Arterial Occlusive Disease |
| Lead sponsor | Harvest Technologies, Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Ischemia |
| Intervention type | Biological, Device |
| Interventions | Harvest Smartprep2 BMAC System, SmartPReP2 BMAC System, placebo |
| Enrollment | 48 |
| Start date | Nov 1, 2007 |
| Primary completion | Mar 1, 2015 |
| Completion | Mar 1, 2015 |
| First posted | Jul 9, 2007 |
| Last update posted | Mar 19, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: